高级检索
当前位置: 首页 > 详情页

Grainyhead-like 2 in development and cancer

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Department of Oncology, Tongren Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, P.R. China [2]Department of Pathogen Biology and Immunology, School of Basic Medical Sciences, Ningxia Medical University, Yinchuan, P.R. China [3]Department of Laboratory Medicine, Changhai Hospital, The Second Military Medical University, Shanghai, P.R. China [4]School of Biomedical Sciences, Faculty of Medicine, the Chinese University of Hong Kong, Hong Kong [5]Division of Translational Cancer Research, Department of Laboratory Medicine, Lund University, Lund, Sweden [6]Lund Stem Cell Center, Department of Laboratory Medicine, Lund University, Lund, Sweden
出处:
ISSN:

关键词: E-cadherin epithelial-to-mesenchymal transition metastasis oncogene tumor suppressor

摘要:
Grainyhead-like 2 is a human homolog of Drosophila grainyhead. It inhibits epithelial-to-mesenchymal transition that is necessary for cell migration, and it is involved in neural tube closure, epithelial morphogenesis, and barrier formation during embryogenesis by regulation of the expression of cell junction proteins such as E-cadherin and vimentin. Cancer shares many common characters with development such as epithelial-to-mesenchymal transition. In addition to its important role in development, grainyhead-like 2 is implicated in carcinogenesis as well. However, the reports on grainyhead-like 2 in various cancers are controversial. Grainyhead-like 2 can act as either a tumor suppressor or an oncogene with the mechanisms not well elucidated. In this review, we summarized recent progress on grainyhead-like 2 in development and cancer in order to get an insight into the regulation network of grainyhead-like 2 and understand the roles of grainyhead-like 2 in various cancers.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2016]版:
大类 | 3 区 医学
小类 | 3 区 肿瘤学
最新[2023]版:
JCR分区:
出版当年[2015]版:
Q2 ONCOLOGY
最新[2023]版:

影响因子: 最新[2023版] 最新五年平均 出版当年[2015版] 出版当年五年平均 出版前一年[2014版] 出版后一年[2016版]

第一作者:
第一作者机构: [1]Department of Oncology, Tongren Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, P.R. China
通讯作者:
通讯机构: [2]Department of Pathogen Biology and Immunology, School of Basic Medical Sciences, Ningxia Medical University, Yinchuan, P.R. China [5]Division of Translational Cancer Research, Department of Laboratory Medicine, Lund University, Lund, Sweden [6]Lund Stem Cell Center, Department of Laboratory Medicine, Lund University, Lund, Sweden [*1]Department of Pathogen Biology and Immunology, School of Basic Medical Sciences, Ningxia Medical University, No. 1160 Shengli Street, Yinchuan 750004, P.R. China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:21169 今日访问量:0 总访问量:1219 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学附属北京同仁医院 技术支持:重庆聚合科技有限公司 地址:北京市东城区东交民巷1号(100730)